Home
Technology
- Concept and Product
- Publications
About us
News
- News
- Media Appearances
Contact

SensArs project is recommended for funding by European Commission

Posted on February 27, 2018March 20, 2018 by SensArs

Click here to view full document.

Bookmark the permalink.

Post navigation

← Ten start-ups selected for the venture leaders Life Science program in Boston

SensArs among the successful stories mentioned by the European Commission →

Search

Search for:

Recent posts

SensArs has been granted FDA Breakthrough Device Designation for SENSY September 6, 2021
SensArs has been awarded with a DIH-HERO Technology Transfer Experiment Grant for treating chronic neuropathic pain May 20, 2021
Our CEO, Francesco Petrini, was nominated among the 35 innovators under 35, from MIT July 9, 2020
SensArs coordinates a consortium of 4 partners coming from 4 countries to take to market its product SENSY October 4, 2019
SensArs financed from the European Commission to explore the feasibility of stimulating the vagal nerve January 1, 2019

Rue du Maupas 38, 1004,
Lausanne

office@sensars.com francesco.petrini@sensars.com

+41779024490

© 2021 SensArs

Powered by Tag-Labs